Market
BSE Prices delayed by 5 minutes... << Prices as on Apr 25, 2025 - 3:55PM >>  ABB India  5499.9 [ -3.21% ] ACC  1936.9 [ -6.34% ] Ambuja Cements  548.45 [ -4.07% ] Asian Paints Ltd.  2430.2 [ -1.40% ] Axis Bank Ltd.  1165.3 [ -3.48% ] Bajaj Auto  8035.4 [ -2.01% ] Bank of Baroda  247.35 [ -1.88% ] Bharti Airtel  1814.2 [ -1.66% ] Bharat Heavy Ele  221.85 [ -3.71% ] Bharat Petroleum  295.4 [ -2.17% ] Britannia Ind.  5410 [ -0.98% ] Cipla  1521.4 [ -1.93% ] Coal India  392.7 [ -1.78% ] Colgate Palm.  2674.2 [ -2.07% ] Dabur India  484.15 [ -1.48% ] DLF Ltd.  653.45 [ -3.98% ] Dr. Reddy's Labs  1171.1 [ -2.53% ] GAIL (India)  186.75 [ -3.36% ] Grasim Inds.  2732.5 [ 0.14% ] HCL Technologies  1579.3 [ -0.48% ] HDFC Bank  1910.35 [ -0.31% ] Hero MotoCorp  3888.4 [ -1.66% ] Hindustan Unilever L  2331.6 [ 0.27% ] Hindalco Indus.  621.85 [ -1.05% ] ICICI Bank  1404.55 [ 0.16% ] Indian Hotels Co  785.5 [ -4.02% ] IndusInd Bank  822.25 [ 0.32% ] Infosys L  1480.2 [ 0.60% ] ITC Ltd.  428.15 [ -0.45% ] Jindal St & Pwr  890 [ -2.08% ] Kotak Mahindra Bank  2203 [ -0.94% ] L&T  3272.15 [ -0.86% ] Lupin Ltd.  2019.1 [ -4.08% ] Mahi. & Mahi  2862.2 [ -1.33% ] Maruti Suzuki India  11685.9 [ -1.81% ] MTNL  42.58 [ -3.56% ] Nestle India  2414.2 [ -0.85% ] NIIT Ltd.  135 [ -6.77% ] NMDC Ltd.  64.97 [ -4.44% ] NTPC  356.3 [ -1.86% ] ONGC  246.35 [ -1.20% ] Punj. NationlBak  99.23 [ -3.35% ] Power Grid Corpo  306.25 [ -2.56% ] Reliance Inds.  1300.05 [ -0.12% ] SBI  798.75 [ -1.78% ] Vedanta  413.05 [ -1.70% ] Shipping Corpn.  173.45 [ -3.99% ] Sun Pharma.  1786.85 [ -0.98% ] Tata Chemicals  834.8 [ -3.39% ] Tata Consumer Produc  1151.8 [ -0.75% ] Tata Motors  654.85 [ -2.00% ] Tata Steel  138.7 [ -1.98% ] Tata Power Co.  387.3 [ -2.20% ] Tata Consultancy  3447.35 [ 1.36% ] Tech Mahindra  1453.4 [ 0.50% ] UltraTech Cement  12219.25 [ 0.46% ] United Spirits  1545 [ -1.00% ] Wipro  240.8 [ -0.80% ] Zee Entertainment En  108.22 [ -5.01% ] 
AstraZeneca Pharma India Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 21812.50 Cr. P/BV 32.11 Book Value (Rs.) 271.74
52 Week High/Low (Rs.) 9211/4800 FV/ML 2/1 P/E(X) 135.05
Bookclosure 05/07/2024 EPS (Rs.) 64.60 Div Yield (%) 0.28
Year End :2024-03 

1. We have audited the accompanying financial statements of AstraZeneca Pharma India Limited (“the Company”), which comprise the Balance Sheet as

at March 31, 2024, and the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of changes in equity and the Statement of cash flows for the year then ended, and notes to the financial statements, including material accounting policy information and other explanatory information.

2. In our opinion and to the best of our information and according to the explanations given to us, the aforesaid financial statements give the information required by the Companies Act, 2013 (“the Act”) in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2024, and total comprehensive income (comprising of profit and other comprehensive income), changes in equity and its cash flows for the year then ended.

Basis for Opinion

3. We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section 143(10) of the Act. Our responsibilities under those Standards are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities

in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key audit matters

4. Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the financial statements of the current period. These matters were addressed in the context of our audit of the financial statements as a whole and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Key audit matter

How our audit addressed the key audit matter

Appropriateness of provisions recognised and contingent liabilities disclosed in respect of certain direct, indirect tax and regulatory matters

(Refer to the Note 19 - “Provisions”, Note 20 - “Current tax liabilities (net)” and Note 32(b) - “Contingent liabilities” to the financial statements)

There are certain direct, indirect tax and regulatory matters pending against the Company.

Direct tax cases include demands in respect of transfer pricing adjustments on transactions with overseas group companies, disallowance of certain expenses incurred, taxability of subvention receipt and certain expense reimbursements and certain other disallowances.

Our procedures included the following:

• Understood, evaluated and tested the design and operating effectiveness of controls in respect of identifying tax and regulatory exposures, its accounting and disclosures thereof.

• Obtained a listing of the litigation matters and, read the correspondence with tax and regulatory authorities and where relevant, the advice received by the management from its external consultants.

• Evaluated the independence, objectivity and competence of the management experts involved.

Key audit matter

How our audit addressed the key audit matter

Indirect tax cases include:

• Along with auditors’ tax and regulatory experts:

• service tax demands raised on expenses incurred in

a.

Gained an understanding of the current status of

foreign currency, reimbursements from overseas group

litigations through our inquiries with management

companies, recovery of notice period pay from former

and determined impact, if any, based on recent

employees and ineligible input tax credit claimed on

rulings and latest developments in respective laws.

certain expenses, and,

b.

Evaluated management’s assessment on the

• goods and services tax demand pertaining to certain

probability of outcome and the magnitude of

category of medicines supplied by the Company.

potential outflow of economic resources in respect

Regulatory matters pertains to demand from National

of:

Pharmaceutical Pricing Authority (NPPA) in respect of alleged

(i) provisions for uncertain tax exposures

overcharging of a patented drug.

based on case history and other available

As at March 31, 2024, the Company has tax demands pertaining to the above direct and indirect tax aggregating to ' 1,403.4 million (including interest and penalties, where

evidence to challenge the valuation and adequacy of the provisions recognised by the Management, and

applicable) of which ' 40.7 million has been provided for and

(ii) regulatory matter.

' 1,362.7 million along with regulatory demand of ' 1,573.9 million has been disclosed as contingent liabilities, which are significant to the financial statements.

c.

Examined the evaluation obtained from the Company’s internal legal counsel to confirm our understanding of outstanding cases.

The Company has filed appeals against these demands with various appellate forums and The Honourable High Court of Delhi which are currently pending for adjudication.

d.

Evaluated the adequacy of disclosures made in the financial statements.

Management judgement is involved in evaluation of the likelihood of ultimate outcome of the tax and regulatory disputes and the probable amount of the provision to be recognised and contingent liabilities to be disclosed and is

Based on the above procedures, we found the judgements made by the Management in recognising provisions and in determining and disclosing contingent liabilities in respect of the aforesaid tax and regulatory matters, to be reasonable.

hence determined to be a key audit matter.

Other Information

5. The Company’s Board of Directors is responsible for the other information. The other information comprises the information included in the Annual Report, but does not include the financial statements and our auditor’s report thereon.

Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Responsibilities of management and those charged with governance for the financial statements

6. The Company’s Board of Directors is responsible for the matters stated in Section 134(5) of the Act with respect to the preparation of these financial statements that give a true and fair view of the financial position, financial performance, changes in equity and cash flows of the Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section 133 of the Act. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the

accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

7. In preparing the financial statements, management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do

so. Those Board of Directors are also responsible for overseeing the Company’s financial reporting process.

Auditor’s responsibilities for the audit of the

financial statements

8. Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

9. As part of an audit in accordance with SAs, we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

a. Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

b. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to

financial statements in place and the operating effectiveness of such controls.

c. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

d. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going concern.

e. Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

10. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

11. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

12. From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would

reasonably be expected to outweigh the public interest benefits of such communication.

Report on other legal and regulatory requirements

13. As required by the Companies (Auditor’s Report) Order, 2020 (“the Order”), issued by the Central Government of India in terms of Section 143(11) of the Act, we give in the ‘Annexure B” a statement on the matters specified in paragraphs 3 and 4 of the Order, to the extent applicable.

14. As required by Section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit.

(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books, except that the daily backup of the primary software application has been kept on servers physically located in India from February 21, 2024, and that the backup of certain ancillary software applications which form part of the books of account and other books and papers maintained in electronic mode has not been maintained on

a daily basis on servers physically located in India during the year and the matters stated in paragraph 14(h)(vi) below on reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 (as amended) (“the Rules”).

(c) The Balance Sheet, the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of changes in equity and the Statement of cash flows dealt with by this Report are in agreement with the books of account.

(d) In our opinion, the aforesaid financial statements comply with the Accounting Standards specified under Section 133 of the Act.

(e) On the basis of the written representations received from the directors taken on record by the Board of Directors, none of the directors is disqualified as on March 31, 2024, from being appointed as a director in terms of Section 164(2) of the Act.

(f) With respect to the maintenance of accounts and other matters connected therewith, reference is made to our remarks in paragraph 14(b) above on reporting under Section 143(3)(b) and paragraph 14(h)(vi) below on reporting under Rule 11(g) of the Rules.

(g) With respect to the adequacy of the internal financial controls with reference to financial statements of the Company and the operating effectiveness of such controls, refer to our separate Report in “Annexure A”.

(h) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its financial statements - Refer Notes 19 and 32(b) to the financial statements.

ii. The Company was not required to recognise a provision as at March 31, 2024, under the applicable law or accounting standards, as it does not have any material foreseeable losses on long-term contract. The Company did not have any derivative contracts as at March 31, 2024.

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company during the year.

iv. (a) The management has represented that,

to the best of its knowledge and belief, as disclosed in the Note 44(vi) to the financial statements, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities (“Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;

(b) The management has represented that, to the best of its knowledge and belief, as disclosed in the Note 44(vii) to the financial statements, no funds have been received by the Company from

any person(s) or entity(ies), including foreign entities (“Funding Parties”), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries; and

(c) Based on such audit procedures that we considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (a) and (b) contain any material misstatement.

v. The dividend declared and paid during the year by the Company is in compliance with Section 123 of the Act.

vi. Based on our examination, which included test checks, the Company has used multiple accounting software for maintaining its books of account which has a feature of recording audit trail (edit log) facility and that has operated throughout the year for all relevant transactions recorded in the software, except that the audit trail is not maintained

at the application level for modification, if any, for certain users with specific access and for direct database changes. During the course of performing our procedures, except for the aforesaid instances of audit trail not maintained at the application and the database levels, where the question of our commenting on whether the audit trail has been tampered with does not arise, we did not notice any instance of audit trail feature being tampered with. The preservation of audit trail for certain ancillary accounting software has a retention period which is lower than that required under the statutory requirements for record retention.

15. The Company has paid/ provided for managerial remuneration in accordance with the requisite approvals mandated by the provisions of Section 197 read with Schedule V to the Act.

For Price Waterhouse & Co Chartered Accountants LLP

Firm Registration Number: 304026E/E-300009

Sharmila Ramaswamy

Partner

Place: Bengaluru Membership Number: 215131

Date: May 27, 2024 UDIN: 24215131BKGSLV8860



 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by